What it is like for people to undergo screening and monitoring for cancer when they have not been diagnosed with the disease itself?
Thesp members' new article questions the widely accepted view that biomedical research is straightforwardly driving improvements in cancer care, demonstrating the importance of social research about living with and beyond cancer in improving cancer services and reducing the risk of cancer. It also underlines the importance of journalists, public commentators and social researchers investigating and taking into account the different experiences and perspectives of a range of people affected by cancer so that their voices can be heard and services shaped to cater for their needs.
Genomic medicine: Patients’, practitioners’ and family members’ hopes for the future. Initial findings from the “Cancer and Society in the 21st Century” project
Choon Key Chekar reports the initial findings from the “Cancer and Society in the 21st Century” project.
Stephanie Parsons (Anglia Ruskin University) shares findings from her research, originally presented at the Leeds conference "Boundaries, Bodies, Borders: The Global Movement of Body Parts".
Abin Thomas (King’s College London) discusses affordable organ transplant in India, in light of the changing political and financial situation of the country, thereby continuing a conversation started at the “Boundaries, Bodies, Borders: The Global Movement of Body Parts” event, held at the University of Leeds on 5th May 2017.
Cecilia Vindrola-Padros (Department of Applied Health Research, University College London) writes on body parts provision and medical travel, continuing a conversation started at the “Boundaries, Bodies, Borders: The Global Movement of Body Parts” event, held at the University of Leeds on 5th May 2017.
Karen Throsby explains how sugar has become the new public health bête noir and discusses her new research project exploring scientific knowledge production, validation and popular appropriation; the role of generation, gender, race an class in the production of embodied citizenship; the politics of food in the context of austerity; and contemporary panics around health and body size.
Julia Swallow discusses the complexities of measuring cost-effectiveness for treatments that target sub-types of cancer, focusing on the recent debate around NHS funding for Kadcyla (trastuzumab emtansine), a targeted breast cancer drug.
Ana Manzano is the principal investigator on the CRIMSON project, which aims to find out how people recently diagnosed with MS make decisions about their treatment.